Citigroup »

Supernus Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 44k 28.94
2023-09-30 $773k 28k 27.57
2023-03-31 $1.3M 35k 36.24
2022-12-31 $1.5M 43k 35.67
2022-09-30 $1.6M 37k 43.48
2021-12-31 $1.4M 47k 29.08
2021-03-31 $534k 20k 26.24
2020-12-31 $676k 26k 25.59
2020-09-30 $798k 38k 20.80
2020-06-30 $1.2M 52k 23.68
2020-03-31 $634k 35k 18.04
2019-12-31 $1.5M 63k 23.64
2019-09-30 $1.4M 49k 27.50
2019-06-30 $1.7M 52k 33.11
2019-03-31 $1.7M 50k 34.97
2018-12-31 $1.0M 31k 33.30
2018-09-30 $3.5M 69k 50.32
2018-06-30 $2.2M 37k 59.84
2018-03-31 $5.6M 123k 45.84
2017-12-31 $5.2M 131k 39.85
2017-09-30 $5.6M 140k 40.00
2017-06-30 $6.5M 150k 43.10
2017-03-31 $2.2M 71k 31.30
2016-12-31 $2.6M 105k 25.25
2016-09-30 $1.3M 51k 24.72
2016-06-30 $574k 28k 20.36
2015-12-31 $74k 5.7k 13.05
2015-09-30 $75k 5.3k 14.25
2015-06-30 $66k 3.9k 16.92
2014-09-30 $24k 2.8k 8.72
2014-03-31 $52k 5.8k 8.85
2013-12-31 $83k 11k 7.54
2013-09-30 $48k 6.5k 7.40
2013-06-30 $0 628 0.00